Pfizer
PFE
PFE
2,226 hedge funds and large institutions have $150B invested in Pfizer in 2018 Q1 according to their latest regulatory filings, with 110 funds opening new positions, 928 increasing their positions, 970 reducing their positions, and 94 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 2,240 → 2,226 (-14)
3% less capital invested
Capital invested by funds: $154B → $150B (-$4.58B)
4% less repeat investments, than reductions
Existing positions increased: 928 | Existing positions reduced: 970
Holders
2,226
Holding in Top 10
180
Calls
$881M
Puts
$881M
Top Buyers
| 1 | +$318M | |
| 2 | +$281M | |
| 3 | +$246M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$229M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$181M |
Top Sellers
| 1 | -$592M | |
| 2 | -$492M | |
| 3 | -$399M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$231M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$198M |